chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Dizziness, Hyperhidrosis, Muscle tightness, Rash
Clinical narrative: more than likely anxiety; red, splotchy rash on her neck; sweaty; felt slightly dizzy, particularly when moving her head side to side; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; This is a spontaneous report from a contactable pharmacist. A 41-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EK5730), intramuscular (IM) on the left arm on 17Dec2020 at 18:30 at a single dose for COVID-19 immunization at the hospital. The patient's medical history and concomitant medications were not reported. The patient had no other vaccine in four weeks. Approximately 4 minutes after administration, on 17Dec2020 at 18:34, the patient complained of "tightness" in her upper middle quadrant of her stomach, near the xiphoid process. At that time (18:34), her heart rate (HR) was 140. At 18:40, her HR was 96. At 18:44, the patient had a red, splotchy rash on her neck. The patient received 25 mg of diphenhydramine (BENADRYL) orally. The patient noted that she was sweaty and she felt slightly dizzy, particularly when moving her head side to side. At 18:47, the patient's HR was 80. At 18:52, HR was 84 and at 18:58, HR was 68. The patient stated she felt much better, dizziness seemed to resolve quickly per patient's report. She was able to ambulate and turn her head side to side with no further difficulties. Throughout the episode, the patient denied nausea, shortness of breath, itching, urticaria or any other rash besides the redness on her neck. After discussion with the physician (MD), nurse (RN), and doctor of pharmacy (PharmD), who were present for the vaccine administration and reaction, it was determined that this was more than likely anxiety (17Dec2020 at 18:45) and not an allergic/anaphylactic reaction. The patient had no Covid prior vaccination and not Covid tested post vaccination. The events were assessed as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of "more than likely anxiety; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; red, splotchy rash on her neck; sweaty; and felt slightly dizzy, particularly when moving her head side to side." The patient recovered from all the events on an unspecified date.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash macular
Clinical narrative: more than likely anxiety; red, splotchy rash on her neck; sweaty; felt slightly dizzy, particularly when moving her head side to side; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; This is a spontaneous report from a contactable pharmacist. A 41-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EK5730), intramuscular (IM) on the left arm on 17Dec2020 at 18:30 at a single dose for COVID-19 immunization at the hospital. The patient's medical history and concomitant medications were not reported. The patient had no other vaccine in four weeks. Approximately 4 minutes after administration, on 17Dec2020 at 18:34, the patient complained of "tightness" in her upper middle quadrant of her stomach, near the xiphoid process. At that time (18:34), her heart rate (HR) was 140. At 18:40, her HR was 96. At 18:44, the patient had a red, splotchy rash on her neck. The patient received 25 mg of diphenhydramine (BENADRYL) orally. The patient noted that she was sweaty and she felt slightly dizzy, particularly when moving her head side to side. At 18:47, the patient's HR was 80. At 18:52, HR was 84 and at 18:58, HR was 68. The patient stated she felt much better, dizziness seemed to resolve quickly per patient's report. She was able to ambulate and turn her head side to side with no further difficulties. Throughout the episode, the patient denied nausea, shortness of breath, itching, urticaria or any other rash besides the redness on her neck. After discussion with the physician (MD), nurse (RN), and doctor of pharmacy (PharmD), who were present for the vaccine administration and reaction, it was determined that this was more than likely anxiety (17Dec2020 at 18:45) and not an allergic/anaphylactic reaction. The patient had no Covid prior vaccination and not Covid tested post vaccination. The events were assessed as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of "more than likely anxiety; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; red, splotchy rash on her neck; sweaty; and felt slightly dizzy, particularly when moving her head side to side." The patient recovered from all the events on an unspecified date.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Anxiety, Dizziness, Hyperhidrosis, Rash
Clinical narrative: more than likely anxiety; red, splotchy rash on her neck; sweaty; felt slightly dizzy, particularly when moving her head side to side; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; This is a spontaneous report from a contactable pharmacist. A 41-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EK5730), intramuscular (IM) on the left arm on 17Dec2020 at 18:30 at a single dose for COVID-19 immunization at the hospital. The patient's medical history and concomitant medications were not reported. The patient had no other vaccine in four weeks. Approximately 4 minutes after administration, on 17Dec2020 at 18:34, the patient complained of "tightness" in her upper middle quadrant of her stomach, near the xiphoid process. At that time (18:34), her heart rate (HR) was 140. At 18:40, her HR was 96. At 18:44, the patient had a red, splotchy rash on her neck. The patient received 25 mg of diphenhydramine (BENADRYL) orally. The patient noted that she was sweaty and she felt slightly dizzy, particularly when moving her head side to side. At 18:47, the patient's HR was 80. At 18:52, HR was 84 and at 18:58, HR was 68. The patient stated she felt much better, dizziness seemed to resolve quickly per patient's report. She was able to ambulate and turn her head side to side with no further difficulties. Throughout the episode, the patient denied nausea, shortness of breath, itching, urticaria or any other rash besides the redness on her neck. After discussion with the physician (MD), nurse (RN), and doctor of pharmacy (PharmD), who were present for the vaccine administration and reaction, it was determined that this was more than likely anxiety (17Dec2020 at 18:45) and not an allergic/anaphylactic reaction. The patient had no Covid prior vaccination and not Covid tested post vaccination. The events were assessed as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of "more than likely anxiety; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; red, splotchy rash on her neck; sweaty; and felt slightly dizzy, particularly when moving her head side to side." The patient recovered from all the events on an unspecified date.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, Rash macular
Clinical narrative: more than likely anxiety; red, splotchy rash on her neck; sweaty; felt slightly dizzy, particularly when moving her head side to side; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; This is a spontaneous report from a contactable pharmacist. A 41-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EK5730), intramuscular (IM) on the left arm on 17Dec2020 at 18:30 at a single dose for COVID-19 immunization at the hospital. The patient's medical history and concomitant medications were not reported. The patient had no other vaccine in four weeks. Approximately 4 minutes after administration, on 17Dec2020 at 18:34, the patient complained of "tightness" in her upper middle quadrant of her stomach, near the xiphoid process. At that time (18:34), her heart rate (HR) was 140. At 18:40, her HR was 96. At 18:44, the patient had a red, splotchy rash on her neck. The patient received 25 mg of diphenhydramine (BENADRYL) orally. The patient noted that she was sweaty and she felt slightly dizzy, particularly when moving her head side to side. At 18:47, the patient's HR was 80. At 18:52, HR was 84 and at 18:58, HR was 68. The patient stated she felt much better, dizziness seemed to resolve quickly per patient's report. She was able to ambulate and turn her head side to side with no further difficulties. Throughout the episode, the patient denied nausea, shortness of breath, itching, urticaria or any other rash besides the redness on her neck. After discussion with the physician (MD), nurse (RN), and doctor of pharmacy (PharmD), who were present for the vaccine administration and reaction, it was determined that this was more than likely anxiety (17Dec2020 at 18:45) and not an allergic/anaphylactic reaction. The patient had no Covid prior vaccination and not Covid tested post vaccination. The events were assessed as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of "more than likely anxiety; "tightness" in the upper middle quadrant of her stomach, near the xiphoid process; HR was 140; red, splotchy rash on her neck; sweaty; and felt slightly dizzy, particularly when moving her head side to side." The patient recovered from all the events on an unspecified date.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Feeling abnormal, Flushing, Pyrexia
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Somnolence
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio normal, Aspartate aminotransferase normal, Basophil count normal, Blood albumin normal
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatinine normal
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood urea nitrogen/creatinine ratio, Blood urea normal
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Carbon dioxide normal, Electrocardiogram normal, Eosinophil count normal, Feeling abnormal, Flushing
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Glomerular filtration rate normal, Haematocrit normal, Haemoglobin normal, Immunoglobulins normal, Influenza like illness
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphocyte count normal, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume normal
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic function test, Monocyte count normal, Neutrophil count normal, Neutrophil function test abnormal, Platelet count normal
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Protein total normal, Pyrexia, Red blood cell count normal, Red cell distribution width normal, White blood cell count normal
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chills, Dyspnoea, Electrocardiogram, Fatigue
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling hot, Headache, Influenza like illness
Clinical narrative: First day I was in PPE I started to get really hot , trouble breathing , feeling flu like symptoms  Second day . was extremely hot,  trouble breathing again ,  Tiredness  , chills, headaches ,
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Feeling hot, Flushing, Palpitations, Paraesthesia
Clinical narrative: heart began to pound; a warm tingling through my abdomen and chest with flushing to my face; a warm tingling through my abdomen and chest with flushing to my face; a warm tingling through my abdomen and chest with flushing to my face; a metallic sort of taste in my mouth; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration on left arm on 18Dec2020 at 10:00 AM at single dose for COVID-19 immunisation at hospital. Medical history included history of svt (supraventricular tachycardia), patient had no allergies to medications, food, or any other products. Concomitant medication included escitalopram oxalate (LEXAPRO), colecalciferol (VITAMIN D) and levocetirizine dihydrochloride (XYZAL). About five minutes after vaccination on 18Dec2020, the patient experienced a warm tingling through her abdomen and chest with flushing to her face, a metallic sort of taste in her mouth and her heart began to pound. The tingling subsided after a couple minutes and heart rate returned to normal over the next 10 minutes. The patient was monitored by the clinic nurses for another 30 minutes before released. The patient felt warm for the rest of the day but no further effects. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient hadn't been tested for COVID-19. The patient did not receive any treatment for events. The outcome of events was recovered on 18Dec2020.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Flushing, Palpitations, Paraesthesia, Skin warm
Clinical narrative: heart began to pound; a warm tingling through my abdomen and chest with flushing to my face; a warm tingling through my abdomen and chest with flushing to my face; a warm tingling through my abdomen and chest with flushing to my face; a metallic sort of taste in my mouth; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration on left arm on 18Dec2020 at 10:00 AM at single dose for COVID-19 immunisation at hospital. Medical history included history of svt (supraventricular tachycardia), patient had no allergies to medications, food, or any other products. Concomitant medication included escitalopram oxalate (LEXAPRO), colecalciferol (VITAMIN D) and levocetirizine dihydrochloride (XYZAL). About five minutes after vaccination on 18Dec2020, the patient experienced a warm tingling through her abdomen and chest with flushing to her face, a metallic sort of taste in her mouth and her heart began to pound. The tingling subsided after a couple minutes and heart rate returned to normal over the next 10 minutes. The patient was monitored by the clinic nurses for another 30 minutes before released. The patient felt warm for the rest of the day but no further effects. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient hadn't been tested for COVID-19. The patient did not receive any treatment for events. The outcome of events was recovered on 18Dec2020.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Fatigue, Injection site pain, Malaise
Clinical narrative: Chills; fatigue; malaise; joint and muscle aches all over body as well as at and around injection site; joint and muscle aches all over body as well as at and around injection site; joint and muscle aches all over body as well as at and around injection site; mild fever: 99.6 oral Fahrenheit; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received bnt162b2 (BNT162B2) lot number: Ek5730, expiration date: not reported, via an unspecified route of administration in the left arm, first dose on 17Dec2020 09:45 at a single dose for immunization. Medical history included allergies to cephalosporins. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. On 17Dec2020 at 04:00 pm, the patient experienced chills, fatigue, malaise, joint and muscle aches all over body as well as at and around injection site, mild fever of 99.6 oral Fahrenheit, lasting two days with lessening severity so far.The events were reported non-serious with no treatment received. The patient had no covid prior vaccination nor had he tested post vaccination. The outcome of chills, fatigue, malaise, joint and muscle aches all over body as well as at and around injection site, mild fever: 99.6 oral Fahrenheit was recovering.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Chills; fatigue; malaise; joint and muscle aches all over body as well as at and around injection site; joint and muscle aches all over body as well as at and around injection site; joint and muscle aches all over body as well as at and around injection site; mild fever: 99.6 oral Fahrenheit; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received bnt162b2 (BNT162B2) lot number: Ek5730, expiration date: not reported, via an unspecified route of administration in the left arm, first dose on 17Dec2020 09:45 at a single dose for immunization. Medical history included allergies to cephalosporins. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. On 17Dec2020 at 04:00 pm, the patient experienced chills, fatigue, malaise, joint and muscle aches all over body as well as at and around injection site, mild fever of 99.6 oral Fahrenheit, lasting two days with lessening severity so far.The events were reported non-serious with no treatment received. The patient had no covid prior vaccination nor had he tested post vaccination. The outcome of chills, fatigue, malaise, joint and muscle aches all over body as well as at and around injection site, mild fever: 99.6 oral Fahrenheit was recovering.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Chills; fatigue; malaise; joint and muscle aches all over body as well as at and around injection site; joint and muscle aches all over body as well as at and around injection site; joint and muscle aches all over body as well as at and around injection site; mild fever: 99.6 oral Fahrenheit; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received bnt162b2 (BNT162B2) lot number: Ek5730, expiration date: not reported, via an unspecified route of administration in the left arm, first dose on 17Dec2020 09:45 at a single dose for immunization. Medical history included allergies to cephalosporins. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. On 17Dec2020 at 04:00 pm, the patient experienced chills, fatigue, malaise, joint and muscle aches all over body as well as at and around injection site, mild fever of 99.6 oral Fahrenheit, lasting two days with lessening severity so far.The events were reported non-serious with no treatment received. The patient had no covid prior vaccination nor had he tested post vaccination. The outcome of chills, fatigue, malaise, joint and muscle aches all over body as well as at and around injection site, mild fever: 99.6 oral Fahrenheit was recovering.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Fatigue; Nausea; This is a spontaneous report from a contactable consumer (patient) and contactable Other healthcare professional. A 41-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EH9899), via an unspecified route of administration (left arm) on 18Dec2020 08:45 at single dose for immunization. Medical history included endometriosis and allergies to lavender and stevia. Concomitant medication included levonorgestrel for birth control. The patient previously took metoclopramide hydrochloride (REGLAN) experienced allergies. On 18Dec2020 03:00 PM, the patient experienced fatigue and nausea. The most recent COVID-19 vaccine was administered in the hospital. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the events. The events recovered on unspecified date in Dec2020.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Condition aggravated, Heart rate increased, Paraesthesia, Sleep disorder
Clinical narrative: had a high level of anxiety with a heart rate of approximately 100-120 bpm for about 1-2 hours; had a tingling feeling all over during this time; This is a spontaneous report from a contactable consumer. A 31-year-old male patient started to receive bnt162b2 (BNT162B2), via an unspecified route of administration from 17Dec2020 08:15 to 17Dec2020 08:15 at a single dose for COVID-19 vaccine. Medical history included intermittent anxiety. There were no concomitant medications.  It was reported by the patient that the night of vaccination he woke up from sleep around 0200 and had a high level of anxiety with a heart rate of approximately 100-120 bpm for about 1-2 hours. He also had a tingling feeling all over during this time. The outcome of the events was recovering. Information about Lot/batch no has been requested.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Condition aggravated, Paraesthesia
Clinical narrative: had a high level of anxiety with a heart rate of approximately 100-120 bpm for about 1-2 hours; had a tingling feeling all over during this time; This is a spontaneous report from a contactable consumer. A 31-year-old male patient started to receive bnt162b2 (BNT162B2), via an unspecified route of administration from 17Dec2020 08:15 to 17Dec2020 08:15 at a single dose for COVID-19 vaccine. Medical history included intermittent anxiety. There were no concomitant medications.  It was reported by the patient that the night of vaccination he woke up from sleep around 0200 and had a high level of anxiety with a heart rate of approximately 100-120 bpm for about 1-2 hours. He also had a tingling feeling all over during this time. The outcome of the events was recovering. Information about Lot/batch no has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Erythema, Rash macular, Tachycardia
Clinical narrative: 10 minutes after receiving the vaccine, I became tachycardic. Heart rate was in the 150s. I believe the rest of my vital signs were normally initially, but about 10 minutes after the tachycardia started, my BP was 170/110. I remained tachycardic so was sent to the ER. I continued to have waxing and waning tachycardia during my ED stay. Per MD, EKG, BMP, CBC were all normal. I did not receive any medications. After about 3 hours of monitoring, my heart rate was under 100 at rest so was discharged home. For the next 24 hours, with minimal exertion (talking, walking on flat surface) my heart rate would elevated into the 110-120s. 48 hours after vaccine, my heart rate returned to normal. I will be following up with cardiology 12/28/2020
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Electrocardiogram normal, Full blood count normal, Metabolic function test normal, Tachycardia
Clinical narrative: 10 minutes after receiving the vaccine, I became tachycardic. Heart rate was in the 150s. I believe the rest of my vital signs were normally initially, but about 10 minutes after the tachycardia started, my BP was 170/110. I remained tachycardic so was sent to the ER. I continued to have waxing and waning tachycardia during my ED stay. Per MD, EKG, BMP, CBC were all normal. I did not receive any medications. After about 3 hours of monitoring, my heart rate was under 100 at rest so was discharged home. For the next 24 hours, with minimal exertion (talking, walking on flat surface) my heart rate would elevated into the 110-120s. 48 hours after vaccine, my heart rate returned to normal. I will be following up with cardiology 12/28/2020
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Headache, Hot flush, Hyperhidrosis, Hypoaesthesia
Clinical narrative: I got a strong metallic taste; About 30 seconds later my entire body started to tingle and I couldn't feel my hands or feet; My heart started to pound out of my chest; headache; I got an extreme hot flash and all my coworkers said I looked bright red and glassy eyed; became drenched in sweat and had to sit down for about 15 minutes with cold packs; she looked bright red and glassy eyed; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received her first dose of bnt162b2 (PFIZER COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration on 18Dec2020 at 14:15 on her left arm at single dose for COVID-19 immunization. Medical history included hypothyroid- well controlled with levothyroxine and known allergies: Penicillin, sulfa, cephalosporin. Concomitant medications in two weeks included levothyroxine, multivitamin, ascorbic acid (VIT C), colecalciferol (VIT D3). It was reported that on 18Dec2020 at 14:15, the injection was painless and she felt great. About 30 seconds later she entire body started to tingle and she couldn't feel her hands or feet. Her heart started to pound out of her chest. She got a strong metallic taste. This subsided after 1-2 minutes. She went back to feeling good. Then about 15 minutes later, on 18Dec2020, the patient got an extreme hot flash and all her coworkers said she looked bright red and glassy eyed. She became drenched in sweat and had to sit down for about 15 minutes with cold packs. Then it subsided again. She had a few more hot flashes and headache the remainder of the evening, but felt generally pretty good ever since. No treatment was received for the adverse event, prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered in Dec2020.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Pain in extremity, Palpitations, Paraesthesia, Tachycardia
Clinical narrative: I got a strong metallic taste; About 30 seconds later my entire body started to tingle and I couldn't feel my hands or feet; My heart started to pound out of my chest; headache; I got an extreme hot flash and all my coworkers said I looked bright red and glassy eyed; became drenched in sweat and had to sit down for about 15 minutes with cold packs; she looked bright red and glassy eyed; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received her first dose of bnt162b2 (PFIZER COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration on 18Dec2020 at 14:15 on her left arm at single dose for COVID-19 immunization. Medical history included hypothyroid- well controlled with levothyroxine and known allergies: Penicillin, sulfa, cephalosporin. Concomitant medications in two weeks included levothyroxine, multivitamin, ascorbic acid (VIT C), colecalciferol (VIT D3). It was reported that on 18Dec2020 at 14:15, the injection was painless and she felt great. About 30 seconds later she entire body started to tingle and she couldn't feel her hands or feet. Her heart started to pound out of her chest. She got a strong metallic taste. This subsided after 1-2 minutes. She went back to feeling good. Then about 15 minutes later, on 18Dec2020, the patient got an extreme hot flash and all her coworkers said she looked bright red and glassy eyed. She became drenched in sweat and had to sit down for about 15 minutes with cold packs. Then it subsided again. She had a few more hot flashes and headache the remainder of the evening, but felt generally pretty good ever since. No treatment was received for the adverse event, prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered in Dec2020.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Erythema, Feeling abnormal, Glassy eyes, Heart sounds abnormal
Clinical narrative: I got a strong metallic taste; About 30 seconds later my entire body started to tingle and I couldn't feel my hands or feet; My heart started to pound out of my chest; headache; I got an extreme hot flash and all my coworkers said I looked bright red and glassy eyed; became drenched in sweat and had to sit down for about 15 minutes with cold packs; she looked bright red and glassy eyed; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received her first dose of bnt162b2 (PFIZER COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration on 18Dec2020 at 14:15 on her left arm at single dose for COVID-19 immunization. Medical history included hypothyroid- well controlled with levothyroxine and known allergies: Penicillin, sulfa, cephalosporin. Concomitant medications in two weeks included levothyroxine, multivitamin, ascorbic acid (VIT C), colecalciferol (VIT D3). It was reported that on 18Dec2020 at 14:15, the injection was painless and she felt great. About 30 seconds later she entire body started to tingle and she couldn't feel her hands or feet. Her heart started to pound out of her chest. She got a strong metallic taste. This subsided after 1-2 minutes. She went back to feeling good. Then about 15 minutes later, on 18Dec2020, the patient got an extreme hot flash and all her coworkers said she looked bright red and glassy eyed. She became drenched in sweat and had to sit down for about 15 minutes with cold packs. Then it subsided again. She had a few more hot flashes and headache the remainder of the evening, but felt generally pretty good ever since. No treatment was received for the adverse event, prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered in Dec2020.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hot flush, Hyperhidrosis, Palpitations, Paraesthesia
Clinical narrative: I got a strong metallic taste; About 30 seconds later my entire body started to tingle and I couldn't feel my hands or feet; My heart started to pound out of my chest; headache; I got an extreme hot flash and all my coworkers said I looked bright red and glassy eyed; became drenched in sweat and had to sit down for about 15 minutes with cold packs; she looked bright red and glassy eyed; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received her first dose of bnt162b2 (PFIZER COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration on 18Dec2020 at 14:15 on her left arm at single dose for COVID-19 immunization. Medical history included hypothyroid- well controlled with levothyroxine and known allergies: Penicillin, sulfa, cephalosporin. Concomitant medications in two weeks included levothyroxine, multivitamin, ascorbic acid (VIT C), colecalciferol (VIT D3). It was reported that on 18Dec2020 at 14:15, the injection was painless and she felt great. About 30 seconds later she entire body started to tingle and she couldn't feel her hands or feet. Her heart started to pound out of her chest. She got a strong metallic taste. This subsided after 1-2 minutes. She went back to feeling good. Then about 15 minutes later, on 18Dec2020, the patient got an extreme hot flash and all her coworkers said she looked bright red and glassy eyed. She became drenched in sweat and had to sit down for about 15 minutes with cold packs. Then it subsided again. She had a few more hot flashes and headache the remainder of the evening, but felt generally pretty good ever since. No treatment was received for the adverse event, prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered in Dec2020.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Aches; mild nausea; chills; fever up to 100.8 for 6-8 hours; Headache; fatigue; This is spontaneous report from a contactable consumer.   A 63-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular (left arm), on 16Dec2020 at single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus, hypothyroidism, Raynaud's phenomenon, drug hypersensitivity (to sulfadiazine, erythromycin). The patient experienced aches on 16Dec2020 18:00, mild nausea on 16Dec2020 18:00, chills on 16Dec2020 18:00, fever up to 100.8 for 6-8 hours on 16Dec2020 18:00, headache on 16Dec2020 18:00, fatigue on 16Dec2020 18:00. The action taken in response to the events for BNT162B2 was not applicable. The outcome of the events was recovered in Dec2020  Information about lot/batch number has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Aches; mild nausea; chills; fever up to 100.8 for 6-8 hours; Headache; fatigue; This is spontaneous report from a contactable consumer.   A 63-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular (left arm), on 16Dec2020 at single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus, hypothyroidism, Raynaud's phenomenon, drug hypersensitivity (to sulfadiazine, erythromycin). The patient experienced aches on 16Dec2020 18:00, mild nausea on 16Dec2020 18:00, chills on 16Dec2020 18:00, fever up to 100.8 for 6-8 hours on 16Dec2020 18:00, headache on 16Dec2020 18:00, fatigue on 16Dec2020 18:00. The action taken in response to the events for BNT162B2 was not applicable. The outcome of the events was recovered in Dec2020  Information about lot/batch number has been requested.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Comminuted fracture, Epistaxis, Facial bones fracture, Haemorrhage, Loss of consciousness
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Subcutaneous haematoma, Tenderness
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone, Chest X-ray, Computerised tomogram head, Computerised tomogram neck, Echocardiogram
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Face injury, Facial bones fracture, Fall, Full blood count
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemorrhage, Loss of consciousness, Metabolic function test, Skin laceration, Thyroxine free
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: X-ray limb
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Computerised tomogram, Echocardiogram, Electrocardiogram
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial bones fracture, Fall, Inappropriate schedule of product administration, Loss of consciousness, Skin laceration
Clinical narrative: Sudden complete loss of consciousness (not vasovagal, no prodrome) while walking along hospital hall; unprotected fall onto face; laceration along entire nose, around L eye; multiple nasal fractures; blowout fracture of left orbit; heavy blood loss. Found unconscious by Security Guard, taken to emergency department for initial care where I regained consciousness, then admitted to hospital for 3-day stay (Hospital). ED doctor saw me first and ordered the initial evaluation.   Am now at home; scheduled in 6 days for surgery concerning orbital fractures and treatment of nasal fractures (bridge and tip)
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Injection site swelling, Myalgia, Pyrexia
Clinical narrative: Fever of 101; myalgias; injection site swelling and pain; injection site swelling and pain; This is a spontaneous report from a contactable physician. This physician reported for himself. A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular on18Dec2020 09:00 AM at single for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Vaccine location was Left arm and it was the first dose. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever of 101, generalized myalgias, injection site swelling and pain on 18Dec2020 21:00. Acetaminophen 500 mg q6h (Every 6 hours) for 2 days was received as treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on an unknown date in Dec2020.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tenosynovitis
Clinical narrative: tenosynovitis L 2 finger, felt most on back of hand, worse with flexion, extension; This is a spontaneous report from a contactable physician. A 64-year-old male patient received first dose of bnt162b2, intramuscularly at site of left arm at 09:15 on 19Dec2020 at single dose for COVID-19 immunization. Medical history included allergies: bananas, kiwi, avocado, latex. Concomitant medication included atorvastatin in Dec2020. The patient experienced tenosynovitis l 2 finger, felt most on back of hand, worse with flexion, extension at 13:00 on 19Dec2020. The patient took advil 600 TID as treatment received for event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of event was recovering.  Information on the Lot/Batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Injection site pain, Limb discomfort, Muscular weakness
Clinical narrative: Tachycardia, heaviness in left arm, dizzy.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Palpitations, Paraesthesia, Tachycardia
Clinical narrative: Tachycardia, heaviness in left arm, dizzy.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Limb discomfort, Tachycardia
Clinical narrative: Tachycardia, heaviness in left arm, dizzy.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Injected limb mobility decreased, Injection site pain, Insomnia
Clinical narrative: fever; body aches; headache; sharp pain in my left arm; limited in mobility to bed; This is a spontaneous report from a contactable consumer reporting for herself.  A 21-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot Number: EH9899), via an unspecified route of administration in the left arm on 18Dec2020 13:45 at single dose for covid-19 immunisation. Medical history included asthma, factor v deficiency, covid-19 and allergy to bee venom. The patient was tested positive for COVID on 10Nov2020 and was asymptomatic. Concomitant medication included benzathine benzylpenicillin (DEPO PEN). On 18Dec2020 at 23:00 (the night following the vaccine) the patient woke with a fever, body aches, headache, and a sharp pain in her left arm. She was limited in mobility to bed. these symptoms continued throughout the next day. The patient took ibuprofen but that had no effect. Diphenhydramine hydrochloride; paracetamol (TYLENOL PM) was able to reduce her fever on the second night so that she was able to sleep. Most of her symptoms started to clear up by 20Dec2020. The outcome of the events was recovering.